BioXcel Therapeutics, Inc. (BTAI) › Capital ExpendituresBioXcel Therapeutics, Inc. (BTAI) — Capital ExpendituresAnnual figures by period end, from SEC filings.2018-12-31: $340.0K2019-12-31: $870.0K2020-12-31: $316.0K2021-12-31: $445.0K2022-12-31: $139.0K2023-12-31: $20.0K2024-12-31: $02025-12-31: $0$02018-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$0—2026-03-27From 2025-01-012024-12-31$0-100.0%2026-03-27From 2024-01-012023-12-31$20.0K-85.6%2025-03-28From 2023-01-012022-12-31$139.0K-68.8%2024-03-22From 2022-01-012021-12-31$445.0K+40.8%2023-03-16From 2021-01-012020-12-31$316.0K-63.7%2022-03-11From 2020-01-012019-12-31$870.0K+155.9%2021-03-12From 2019-01-012018-12-31$340.0K—2020-03-09From 2018-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)